Swiss Re’s Xylem XYL Stock Holding History

Swiss Re’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-84	Closed	-$10K	–	283
2026 Q1	$10K	Hold	84	–	–	0.06%	218
2025 Q4	$11.4K	Buy	+84	New	+$12.1K	﹤0.01%	206

Other funds holding XYL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Swiss Re's XYL Position: Q2 2026 in Review

Swiss Re sold out of Xylem (XYL) in Q2 2026, closing a stake of 84 shares — an estimated $10K sold.

Swiss Re first reported a position in XYL in Q4 2025 and held it in 2 quarters. The position peaked at $11.4K in Q4 2025. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

Swiss Re reported no remaining Xylem position as of Q2 2026 after selling out during the quarter.
Swiss Re sold 84 Xylem shares in Q2 2026, an estimated $10K.
Swiss Re first reported a position in Xylem in Q4 2025 and held it in 2 quarters.
Swiss Re's Xylem position peaked at $11.4K in Q4 2025.
1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Swiss Re's 13F filing for Q2 2026, filed 11 Aug 2026.